Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins… - European …, 2018 - Eur Respiratory Soc
We assessed safety and tolerability of treatment with pirfenidone (1602–2403 mg· day− 1)
and nintedanib (200–300 mg· day− 1) in patients with idiopathic pulmonary fibrosis (IPF) …
and nintedanib (200–300 mg· day− 1) in patients with idiopathic pulmonary fibrosis (IPF) …
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
KR Flaherty, CD Fell, JT Huggins, H Nunes… - The European …, 2018 - europepmc.org
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins… - The European …, 2018 - pubmed.ncbi.nlm.nih.gov
We assessed safety and tolerability of treatment with pirfenidone (1602-2403 mg· day-1) and
nintedanib (200-300 mg· day-1) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
nintedanib (200-300 mg· day-1) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
Safety of Nintedanib Added to Pirfenidone Treatment for Idiopathic Pulmonary Fibrosis
KR Flaherty, CD Fell, JT Huggins… - European …, 2018 - Eur Respiratory Soc
We assessed safety and tolerability of treatment with pirfenidone (1602–2403 mg/day) and
nintedanib (200–300 mg/day) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
nintedanib (200–300 mg/day) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins, H Nunes… - Eur Respir …, 2018 - researchgate.net
We assessed safety and tolerability of treatment with pirfenidone (1602-2403 mg· day− 1)
and nintedanib (200-300 mg· day− 1) in patients with idiopathic pulmonary fibrosis (IPF) …
and nintedanib (200-300 mg· day− 1) in patients with idiopathic pulmonary fibrosis (IPF) …
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins, H Nunes… - The European …, 2018 - repub.eur.nl
We assessed safety and tolerability of treatment with pirfenidone (1602-2403 mg day-1) and
nintedanib (200-300 mg day-1) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
nintedanib (200-300 mg day-1) in patients with idiopathic pulmonary fibrosis (IPF). This 24 …
[引用][C] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins, H Nunes… - European Respiratory …, 2018 - cir.nii.ac.jp
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
[HTML][HTML] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
KR Flaherty, CD Fell, JT Huggins, H Nunes… - The European …, 2018 - ncbi.nlm.nih.gov
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.
KR Flaherty, CD Fell, JT Huggins, H Nunes… - The European …, 2018 - europepmc.org
Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu …